XML 23 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Activities:      
Net Income $ 120,569 $ 117,699 $ 110,952
Items not affecting cash:      
Depreciation and amortization 108,581 100,352 85,549
Deferred income taxes 608 22,999 23,435
Provision for doubtful receivables 8,800 1,764 1,764
Employee benefit plan (credit) cost 606 (5,796) (8,142)
Equity earnings in investments (12,275) (10,631) (9,136)
Other items 1,483 (388) (1,535)
Changes in working capital items:      
Accounts receivable and unbilled revenues (6,566) 11,174 (16,726)
Inventories 5,542 (850) (22,226)
Prepaid taxes 3,921 (3,178) 1,082
Other current assets 9,972 5,028 (3,729)
Accounts payable 6,491 (5,208) 5,102
Deferred income taxes 18,501 0 0
Other current liabilities (1,711) (2,264) (5,562)
Dividends from investments 8,834 8,508 7,090
Cash contributions to pension and other postretirement plans (7,722) (7,747) (7,308)
Other noncurrent items, net 12,150 6,099 (6,875)
Cash Provided by Operating Activities 277,784 237,561 153,735
Investing Activities:      
Capital expenditures (236,925) (222,071) (175,030)
Capital contributions to investments (4,792) (6,995) (5,185)
Other 230 (954) 70
Cash Used for Investing Activities (241,487) (230,020) (180,145)
Financing Activities:      
Issuance of common stock, net 31,605 0 0
Cash dividends paid on common stock (63,596) (60,393) (57,500)
Repayment of long-term debt (5,146) (54,314) (4,889)
Issuance of long-term debt 50,000 139,300 25,000
(Repayments of) proceeds from short-term debt (38,000) (32,500) 65,000
Other (1,690) (2,576) (2,068)
Cash (Used for) Provided by Financing Activities (26,827) (10,483) 25,543
Change in cash, cash equivalents, and restricted cash: 9,470 (2,942) (867)
Cash, cash equivalents, and restricted cash at beginning of period 15,026 17,968 18,835
Cash, cash equivalents, and restricted cash at end of period 24,496 15,026 17,968
MGE [Member]      
Operating Activities:      
Net Income 112,299 112,370 105,492
Items not affecting cash:      
Depreciation and amortization 108,581 100,352 85,549
Deferred income taxes (433) 21,536 22,767
Provision for doubtful receivables 8,800 1,764 1,764
Employee benefit plan (credit) cost 606 (5,796) (8,142)
Other items 2,247 (241) 672
Changes in working capital items:      
Accounts receivable and unbilled revenues (6,582) 11,130 (16,697)
Inventories 5,542 (850) (22,226)
Prepaid taxes 3,979 (3,871) 912
Other current assets 9,983 5,032 (3,774)
Accounts payable 6,495 (5,209) 5,104
Deferred income taxes 18,501 0 0
Accrued interest and taxes 2,540 1,413 (2,737)
Other current liabilities (2,397) (3,272) (2,541)
Cash contributions to pension and other postretirement plans (7,722) (7,747) (7,308)
Other noncurrent items, net 10,514 5,211 (7,768)
Cash Provided by Operating Activities 272,953 231,822 151,067
Investing Activities:      
Capital expenditures (236,925) (222,071) (175,030)
Other (2,088) (1,956) (1,065)
Cash Used for Investing Activities (239,013) (224,027) (176,095)
Financing Activities:      
Cash dividends paid to parent by MGE (34,500) (41,000) (33,500)
Distributions to parent from noncontrolling interest (22,000) (20,500) (22,000)
Capital contributions from parent 30,750 0 0
Repayment of long-term debt (5,146) (54,314) (4,889)
Issuance of long-term debt 50,000 139,300 25,000
(Repayments of) proceeds from short-term debt (38,000) (32,500) 65,000
Other (1,690) (2,576) (1,881)
Cash (Used for) Provided by Financing Activities (20,586) (11,590) 27,730
Change in cash, cash equivalents, and restricted cash: 13,354 (3,795) 2,702
Cash, cash equivalents, and restricted cash at beginning of period 6,705 10,500 7,798
Cash, cash equivalents, and restricted cash at end of period $ 20,059 $ 6,705 $ 10,500